Hypotrichosis, or inadequate eyelashes, is a treatable condition. Bimatoprost is a prostaglandin analog formulated to extend the active growth phase of eyelash follicles, producing visibly longer, thicker, and darker lashes through a biological mechanism entirely different from systemic hair loss treatments.
Bimatoprost is an FDA-approved prostaglandin analog for eyelash hypotrichosis. Applied once nightly to the upper eyelid margin, it stimulates the anagen (growth) phase of individual lashes while simultaneously increasing the number of follicles in active growth. Results are gradual, consistent, and fully reversible if treatment is stopped.
Most patients achieve full results within 12 to 16 weeks of nightly use. Once you reach your target, maintenance is simple: continue nightly application to sustain results. 3-month supply. Coming Soon.
Includes ongoing provider care & support
Sterile applicators · Platform access & educational content
Bimatoprost does not rely on luck. It relies on follicle biology. These numbers show what the research supports.
Individual results vary. Clinical trial outcomes reflect the FDA-approved indication for hypotrichosis. Bimatoprost is prescribed off-label for cosmetic eyelash enhancement at Obsidian Genetics.
Bimatoprost works at the follicle level by modulating prostaglandin receptor signaling, a pathway entirely separate from hormonal hair loss mechanisms. Here is how it works.
Bimatoprost is a prostaglandin F2α analog that binds follicle prostaglandin receptors, prolonging the anagen (active growth) phase of eyelash follicles. This extension means individual lashes remain in the growth phase longer, resulting in increased final hair length.
Beyond extending growth duration in existing active follicles, bimatoprost increases the proportion of follicles simultaneously in the growth phase. The result is not just longer lashes, but also more lashes in active growth at the same time, producing visibly fuller lash lines.
Activation of prostaglandin receptors in lash follicles stimulates melanogenesis (pigment production) in the lash matrix. This results in naturally darker lash color as a secondary effect of the prostaglandin pathway activation, with no added dyes or pigments.
Correct application is essential for results and safety. Follow these steps nightly for 12 to 16 weeks to achieve full growth.
Remove makeup and contact lenses. Cleanse eyelids thoroughly with a gentle cleanser and pat dry with a clean cloth. No makeup or debris should remain on the eyelid.
Using the provided sterile applicator, apply one drop of bimatoprost along the upper eyelid skin at the base of the upper lashes, drawing a thin line like eyeliner. Do not apply to the lower lid.
Blot any excess solution with a clean tissue immediately. Excess solution on the lower eyelid or surrounding skin can cause unwanted hair growth in those areas. Precision prevents side effects.
Apply nightly at the same time each day. Consistency is essential. Once you reach your desired results, continue nightly use to sustain the growth. Results fade over 4 weeks if treatment stops.
Results are gradual. Here is a realistic week-by-week breakdown of what you will see as bimatoprost works.
Lashes begin growing; changes may not be visibly noticeable yet. Follicles are transitioning into active growth phase.
Length increase becomes apparent to the user. Some darkening may begin. Lashes are noticeably fuller to self and close observers.
Significant length and fullness increase. Darkening is more prominent. Visible change is now clear in most lighting conditions.
Full results achieved. Maximum length, thickness, and darkness. Maintain with continued nightly application. Results plateau at this point.
Lashes gradually return toward baseline over approximately 4 weeks. No rebound overgrowth; simple return to natural state. Reversal is complete and harmless.
Bimatoprost is well-tolerated when applied correctly. The most important warning involves iris pigmentation. Here is what you need to know.
If bimatoprost solution contacts the iris (the colored part of the eye), it can cause permanent brown pigmentation in lighter-colored irises. This is the most significant potential side effect. Correct application to the upper eyelid margin prevents this. Apply precisely; blot excess immediately. Avoid letting solution run into the eye.
The skin around the eye (periorbital area) and the eyelid itself may darken slightly with use. This darkening is reversible and typically resolves within several weeks after stopping treatment. It results from increased melanin production in the skin, similar to the darkening effect on lashes.
Bimatoprost can stimulate hair growth in any area where it contacts skin. If solution spreads to the cheek, lower lid, or surrounding facial skin, fine hair may grow in those areas. This is why precise application and blotting excess is essential. Growth will resolve after stopping treatment.
Some users report mild eye redness, irritation, or a burning sensation. These effects are typically transient and self-limiting. If irritation persists, contact your provider. Do not apply if you have active eye infections or significant ocular disease without provider approval.
Bimatoprost is also used as a glaucoma medication to lower intraocular pressure (IOP). If you have glaucoma, ocular hypertension, or take IOP-lowering medications, you must disclose this to your Obsidian Genetics provider before starting treatment. Your provider will assess whether bimatoprost is appropriate for your eye health. Regular eye exams are recommended if you have any history of glaucoma or elevated IOP.
Pricing
One flat rate. Physician supervision, compounded medication, and ongoing support included.
One-time purchase. Sterile applicators included.
Includes: physician consultation · compounded medication · ongoing provider support · free shipping
FDA Approval Status: Bimatoprost is FDA-approved for the treatment of hypotrichosis (inadequate eyelashes). At Obsidian Genetics, bimatoprost is prescribed for cosmetic eyelash enhancement, which is an off-label use. Off-label prescribing is legal and common when a provider determines it is appropriate for a patient's goals and medical history.
Not Medical Advice: The content on this page is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Consult a qualified healthcare provider before starting any new treatment. All Obsidian Genetics prescriptions are issued following a clinical review by a licensed provider.
Mechanism and Reversibility: Bimatoprost extends the anagen (growth) phase of eyelash follicles through prostaglandin F2α receptor agonism. All effects are reversible; lashes return to baseline within approximately 4 weeks of stopping treatment. Iris pigmentation, if it occurs from solution contact with the eye, is permanent and is the most significant potential side effect.
Clinical Evidence: Eyelash growth efficacy is supported by FDA pivotal clinical trial data evaluated against the Global Eyelash Assessment (GEA) scale at 16 weeks; refer to the FDA-approved Latisse prescribing information for complete trial results. Scalp hair applications remain in the research phase with limited clinical evidence and are not currently prescribed at Obsidian Genetics. Individual results vary.
Bimatoprost is a prostaglandin analog and the active pharmaceutical ingredient referenced throughout this page. Obsidian Genetics is a telehealth platform connecting patients with licensed providers. ©2024 Obsidian Genetics. All rights reserved.